Clinical trial / 2018
Vegan fecal microbiota transplants did not lower TMAO production in metabolic syndrome.
Twenty men with metabolic syndrome received either autologous or lean vegan-donor fecal transplants. After two weeks, vegan-donor transplants altered microbial community structure toward a vegan profile in some participants. However, the intervention caused no functional changes in TMAO synthesis from choline or carnitine, aortic radiotracer uptake, or cytokine generation from isolated immune cells.
- Study type
- Randomized controlled trial
- Who was studied
- 20 men with metabolic syndrome
- What was measured
- TMAO production and vascular inflammation markers
THE PAPER
Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome.
Smits LP, Kootte RS, Levin E, Prodan A, Fuentes S, Zoetendal EG, Wang Z, Levison BS, Cleophas MCP, Kemper EM, Dallinga-Thie GM, Groen AK, Joosten LAB, Netea MG, Stroes ESG, de Vos WM, Hazen SL, Nieuwdorp M. J Am Heart Assoc, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.